GlassScriptPhysician profile
Michelle M Han
NPI 1841223542
$1,240.09
in general payments reported to CMS, 2019-2025
21 companies · $186 in 2025
The $186 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $74.53 · 2021: $49.29 · 2022: $179 · 2023: $231 · 2024: $367 · 2025: $186.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $785.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $785.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $268.49 | 2023-2024 | Qelbree, Qelbree |
| Sanofi-Aventis U.S. LLC | $213.80 | 2023-2025 | |
| Sanofi Pasteur INC. | $119.18 | 2019-2023 | |
| Glaxosmithkline, LLC. | $79.14 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $73.93 | 2020-2024 | Rotateq, M-M-R II, Gardasil 9 |
| Cranial Technologies, INC | $70.47 | 2022-2025 | Doc Band |
| Medtronic, INC. | $64.03 | 2022-2023 | Penditure |
| Pfizer INC. | $57.25 | 2019-2023 | |
| Amarin Pharma, INC. | $32.79 | 2019 | |
| Karl Storz Endoscopy-America | $32.20 | 2024-2025 | Image1 X-Link |
| Bolton Medical INC | $28.60 | 2025 | Thoraflex Hybrid |
| Kowa Pharmaceuticals America, INC. | $28.45 | 2025 | Zoryve |
| W. L. Gore & Associates, INC. | $24.71 | 2022 | |
| Azurity Pharmaceuticals, INC. | $23.08 | 2025 | Alvesco |
| Cvrx, INC. | $22.46 | 2023 | Barostim Neo System |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $19.37 | 2022 | |
| Seqirus USA INC | $18.74 | 2024 | Flucelvax |
| Sobi, INC | $18.58 | 2019 | |
| Amgen INC. | $15.14 | 2019 | |
| Abbvie INC. | $15.11 | 2021 | |
| Krystal Biotech INC | $14.57 | 2023 | Vyjuvek |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Han listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.